Xinyang Shou, Yimin Wang, Ziyi Wang, Zimei Yang, Di Zhang, Qiang Liu. Longer reported amiodarone use is associated with FLI-defined hepatic steatosis and a nutlin-3a-sensitive lipid phenotype in HepG2 cells. // BMC Pharmacology and Toxicology. – 2026. – DOI: 10.1186/s40360-026-01275-0. – URL: https://doi.org/10.1186/s40360-026-01275-0
Xinyang Shou, Yimin Wang, Ziyi Wang, Zimei Yang, Di Zhang, & Qiang Liu (2026). Longer reported amiodarone use is associated with FLI-defined hepatic steatosis and a nutlin-3a-sensitive lipid phenotype in HepG2 cells. BMC Pharmacology and Toxicology. https://doi.org/10.1186/s40360-026-01275-0
Xinyang Shou, et al. “Longer reported amiodarone use is associated with FLI-defined hepatic steatosis and a nutlin-3a-sensitive lipid phenotype in HepG2 cells.” BMC Pharmacology and Toxicology, 2026. doi:10.1186/s40360-026-01275-0.
@article{Shou2026,
title = {Longer reported amiodarone use is associated with FLI-defined hepatic steatosis and a nutlin-3a-sensitive lipid phenotype in HepG2 cells},
author = {Shou, Xinyang and Wang, Yimin and Wang, Ziyi and Yang, Zimei and Zhang, Di and Liu, Qiang},
journal = {BMC Pharmacology and Toxicology},
year = {2026},
doi = {10.1186/s40360-026-01275-0},
url = {https://doi.org/10.1186/s40360-026-01275-0}
}